Yutong Zhao Selected Research

phosphatidylbutanol

5/2009

Phospholipase D-mediated activation of IQGAP1 through Rac1 regulates hyperoxia-induced p47phox translocation and reactive oxygen species generation in lung endothelial cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yutong Zhao Research Topics

Disease

18	Inflammation (Inflammations) 04/2022 - 02/2006
12	Lung Injury 01/2019 - 04/2009
10	Infections 03/2021 - 10/2003
10	Acute Lung Injury 01/2021 - 09/2009
7	Neoplasms (Cancer) 01/2022 - 02/2014
7	Pneumonia (Pneumonitis) 03/2021 - 10/2011
7	Pulmonary Fibrosis (Fibrosing Alveolitis) 10/2019 - 12/2013
6	Asthma (Bronchial Asthma) 01/2021 - 04/2007
6	Fibrosis (Cirrhosis) 01/2020 - 01/2013
6	Sepsis (Septicemia) 06/2017 - 01/2011
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2020 - 02/2014
4	Lung Neoplasms (Lung Cancer) 01/2022 - 11/2014
3	Idiopathic Pulmonary Fibrosis 01/2016 - 12/2013
2	Hypoxia (Hypoxemia) 01/2022 - 10/2016
2	Pulmonary Hypertension 01/2022 - 10/2016
2	Vascular Remodeling 01/2022 - 10/2016
2	Emphysema 09/2021 - 01/2020
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2021 - 01/2018
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2021 - 01/2020
2	Virus Diseases (Viral Diseases) 01/2021 - 03/2020
2	Edema (Dropsy) 12/2019 - 08/2011
2	Hyperoxia 06/2011 - 05/2009
1	Body Weight (Weight, Body) 06/2022
1	Vision Disorders (Hemeralopia) 01/2021
1	Retinal Degeneration 01/2021
1	Liver Diseases (Liver Disease) 01/2021
1	Carcinogenesis 01/2021
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021
1	Listeriosis (Listeria Infection) 01/2021
1	Pathologic Processes 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021
1	Hypersensitivity (Allergy) 01/2021
1	Alcoholic Hepatitis 01/2021

Drug/Important Bio-Agent (IBA)

13	CytokinesIBA 12/2019 - 02/2006
9	Proteins (Proteins, Gene)FDA Link 09/2021 - 09/2009
8	lysophosphatidic acidIBA 01/2021 - 03/2009
6	UbiquitinIBA 01/2020 - 06/2012
6	Lysophosphatidic Acid ReceptorsIBA 08/2016 - 11/2009
5	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2021 - 08/2011
5	Bleomycin (Blenoxane)FDA LinkGeneric 01/2020 - 12/2013
4	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2021 - 05/2009
4	EnzymesIBA 01/2021 - 07/2013
4	Interleukin-33IBA 08/2015 - 06/2012
4	Small Interfering RNA (siRNA)IBA 06/2014 - 04/2008
3	Deubiquitinating EnzymesIBA 09/2021 - 07/2019
3	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2021 - 01/2019
3	LipidsIBA 01/2021 - 10/2011
3	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 12/2019 - 01/2011
3	Ligases (Synthetase)IBA 01/2019 - 06/2012
3	LipopolysaccharidesIBA 06/2017 - 10/2011
3	Cadherins (E-Cadherin)IBA 11/2014 - 09/2009
3	F-Box ProteinsIBA 11/2013 - 06/2012
2	Semaxinib (SU5416)IBA 01/2022 - 10/2016
2	SmokeIBA 09/2021 - 01/2020
2	RNA (Ribonucleic Acid)IBA 01/2021 - 10/2018
2	LigandsIBA 01/2021 - 03/2020
2	CollagenIBA 01/2020 - 01/2016
2	Interleukin-1 (Interleukin 1)IBA 07/2019 - 01/2015
2	Pharmaceutical PreparationsIBA 01/2019 - 01/2018
2	indium-bleomycinIBA 01/2018 - 07/2015
2	Histones (Histone)IBA 06/2017 - 01/2017
2	3- (4- (4- ((1- (2- chlorophenyl)ethoxy)carbonyl amino)-3-methyl-5-isoxazolyl) benzylsulfanyl) propanoic acidIBA 07/2015 - 10/2011
2	EndotoxinsIBA 07/2015 - 09/2009
2	Biomarkers (Surrogate Marker)IBA 01/2015 - 07/2013
2	ChemokinesIBA 10/2011 - 02/2006
2	Tyrosine (L-Tyrosine)FDA Link 05/2009 - 10/2003
2	1-dodecylpyridoxal (PLD)IBA 05/2009 - 10/2003
1	Fatty Acids (Saturated Fatty Acids)IBA 06/2022
1	Indicators and Reagents (Reagents)IBA 04/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	Tamoxifen FDA LinkGeneric 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	MTOR InhibitorsIBA 01/2022
1	NADPH Oxidases (NAD(P)H oxidase)IBA 03/2021
1	Ubiquitin-Specific ProteasesIBA 01/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021
1	abemaciclibIBA 01/2021
1	LysophospholipidsIBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	Amoxicillin (Wymox)FDA LinkGeneric 01/2021
1	Nerve Growth Factors (Neurotrophins)IBA 01/2021
1	Ethanol (Ethyl Alcohol)IBA 01/2021
1	LY3214996IBA 01/2021
1	Adenosine Triphosphate (ATP)IBA 01/2021
1	Neuroprotective AgentsIBA 01/2021
1	Interleukin-22 (IL-22)IBA 01/2021
1	LY3023414IBA 01/2021
1	Pattern Recognition ReceptorsIBA 01/2021
1	Toll-Like Receptor 7IBA 01/2021
1	Proteasome InhibitorsIBA 12/2020
1	VaccinesIBA 03/2020
1	SARS-CoV-2 spike proteinIBA 03/2020
1	Monoclonal AntibodiesIBA 03/2020
1	human ACE2 proteinIBA 03/2020
1	Fibronectins (Fibronectin)IBA 01/2020
1	Insulin-Like Growth Factor I (IGF-1)IBA 11/2019
1	Insulin-Like PeptidesIBA 11/2019

Therapy/Procedure

5	Therapeutics 01/2021 - 03/2011
2	Radiotherapy 10/2011 - 03/2011
1	Oral Administration 01/2021